Matrix Pharma offers a range of innovative healthcare products designed to address various health concerns. Their product lineup includes FeMax®, an iron supplement aimed at improving iron levels safely and effectively, and Myofolic®, which is tailored for women managing Polycystic Ovary Syndrome (PCOS) by supporting hormone balance and insulin function. Other notable products include UCIBON®, which promotes joint mobility and comfort, Entpro® for digestive health, and Ospor®, an oral suspension of probiotics designed to combat different types of diarrhea. Additionally, Prulax® serves as a natural laxative, providing a safe option for those seeking relief from constipation.

The company emphasizes the importance of specialized formulations, such as Emfio®, which is specifically designed for weight management in women with PCOS. This product combines key ingredients like Myo-inositol, D-Chiroinositol, Folic Acid, and Chromium Picolinate to enhance insulin sensitivity and support metabolic health. Matrix Pharma's commitment to quality and innovation is evident in their diverse offerings, which aim to improve overall health and well-being for their customers.

United States

Matrix Pharma Pvt. Ltd. was started in the year 2001 with a vision to be a leading innovative healthcare company. The company develops and offers a range of nutraceutical and pharmaceutical products, including dietary supplements, vitamins, and active pharmaceutical ingredients (API). Matrix Pharma aims to provide high-quality healthcare solutions to its customers and has cemented its position as an innovative player in the industry.

Matrix Pharma

Company Details